{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:47:10Z","timestamp":1775123230450,"version":"3.50.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","funder":[{"name":"Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University Clinical Research 5555 Program","award":["No. IIT-2022-015(HYX)"],"award-info":[{"award-number":["No. IIT-2022-015(HYX)"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>\n                    A 65-year-old woman presented with whole-body pain after a radical gastrectomy of gastric cancer. The patient was enrolled in a clinical trial of comparison\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG and\n                    <jats:sup>18<\/jats:sup>\n                    F-FAPI-04 PET\/CT in recurrent gastrointestinal tumor (No. IIT-2022-015#HYX#). Compared with non-\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG avidity,\n                    <jats:sup>18<\/jats:sup>\n                    F-FAPI-04 PET\/CT showed diffuse inhomogeneous intense tracer uptake of bone marrow. Subsequent bone marrow biopsy confirmed recurrent gastric cancer. This case revealed\n                    <jats:sup>18<\/jats:sup>\n                    F-FAPI-04 might be a promising radiopharmaceutical in the evaluation of bone marrow metastasis from recurrent gastric cancer.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000005787","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:00:17Z","timestamp":1749582017000},"page":"e692-e694","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Intense 18F-FAPI-04 Uptake in Bone Marrow Metastasis From Recurrent Postoperative Gastric Cancer Negative on 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"50","author":[{"given":"Haipeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiucen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rusen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"R1-20251114","doi-asserted-by":"crossref","first-page":"9852632","DOI":"10.1155\/2017\/9852632","article-title":"Bone marrow metastasis is an early stage of bone metastasis in breast cancer detected clinically by F18-FDG-PET\/CT imaging","volume":"2017","author":"Al-Muqbel","year":"2017","journal-title":"Biomed Res Int"},{"key":"R2-20251114","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1007\/s00259-013-2487-7","article-title":"Complementary roles of tumour specific PET tracer 18F-FAMT to 18F-FDG PET\/CT for the assessment of bone metastasis","volume":"40","author":"Morita","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-20251114","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s12282-015-0621-z","article-title":"Diagnostic performance of 18F-fluorodeoxyglucose PET\/CT and bone scintigraphy in breast cancer patients with suspected bone metastasis","volume":"23","author":"Niikura","year":"2016","journal-title":"Breast Cancer"},{"key":"R4-20251114","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.biopha.2012.06.004","article-title":"Early bone marrow metastasis detection: the additional value of FDG-PET\/CT vs. CT imaging","volume":"66","author":"Evangelista","year":"2012","journal-title":"Biomed Pharmacother"},{"key":"R5-20251114","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/RLU.0000000000003263","article-title":"68Ga-FAPI outperforms 18F-FDG PET\/CT in identifying bone metastasis and peritoneal carcinomatosis in a patient with metastatic breast cancer","volume":"45","author":"Pang","year":"2020","journal-title":"Clin Nucl Med"},{"key":"R6-20251114","doi-asserted-by":"crossref","first-page":"e240830","DOI":"10.1148\/radiol.240830","article-title":"Non-fluorine 18 fluorodeoxyglucose-avid bone marrow metastases at gallium 68 fibroblast activation protein inhibitor PET\/CT","volume":"313","author":"Li","year":"2024","journal-title":"Radiology"},{"key":"R7-20251114","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00259-022-06021-2","article-title":"[68Ga]Ga-FAPI PET for the evaluation of digestive system tumors: systematic review and meta-analysis","volume":"50","author":"Huang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R8-20251114","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/RLU.0000000000003099","article-title":"68Ga-FAPI PET\/CT detects gastric signet-ring cell carcinoma in a patient previously treated for prostate cancer","volume":"45","author":"Pang","year":"2020","journal-title":"Clin Nucl Med"},{"key":"R9-20251114","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/RLU.0000000000004604","article-title":"Comparison of 18F-FDG and 68Ga-FAPI-04 uptake in postoperative re-evaluation of gastric, duodenal, and colorectal cancers","volume":"48","author":"Liu","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R10-20251114","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1007\/s00259-022-05799-5","article-title":"[68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET\/CT","volume":"49","author":"Lin","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-20251114","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00259-021-05494-x","article-title":"Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET\/CT in evaluating the extent of disease in gastric adenocarcinoma","volume":"49","author":"Kuten","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:00:59Z","timestamp":1763125259000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005787","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"2024-12-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}